Skip to main content
GutCited

Lactobacillus casei के लिए Antibiotic-Associated Diarrhea (AAD)

C

Some evidence for AAD prevention in hospitalized elderly patients (PLACIDE trial was negative for primary outcome but showed trends).

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dcasei\u0026condition\u003Dantibiotic\u002Dassociated\u002Ddiarrhea'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

Some evidence for AAD prevention in hospitalized elderly patients (PLACIDE trial was negative for primary outcome but showed trends).

Key Study Findings

In Vitro
Complex probiotics alleviate ampicillin-induced antibiotic-associated diarrhea in mice.
Dose: 4-strain probiotic mixture बनाम: Ampicillin-induced AAD model Outcome: Gut microbiota recovery and immune modulation प्रभाव: None None

जनसंख्या: Ampicillin-induced AAD mouse model

Meta-Analysis n=692
Which probiotic has the best effect on preventing Clostridium difficile-associated diarrhea? A systematic review and …
Dose: None बनाम: Control group Outcome: the incidence rates of AAD and CDAD, and … प्रभाव: OR 0.39, None

जनसंख्या: Diarrhea patients

Randomized Controlled Trial n=314 4.3 weeks Double-blind
Probiotic Yogurt for the Prevention of Antibiotic-associated Diarrhea in Adults: A Randomized Double-blind Placebo-controlled Trial.
Dose: None बनाम: Placebo Outcome: Bowel function प्रभाव: None p=0.30

जनसंख्या: None

Systematic Review n=228
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
Dose: None बनाम: None Outcome: Diarrhea outcomes प्रभाव: None None

जनसंख्या: None

Controlled Clinical Trial n=32 4.3 weeks Open-label
Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic …
Dose: 10 billion L. casei, 2 bottles/day बनाम: Contemporary matched controls Outcome: Safety, feasibility, AAD incidence प्रभाव: None None

जनसंख्या: ICU patients on antibiotics

Meta-Analysis n=9569
Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis.
Dose: None बनाम: Placebo/no probiotic Outcome: Prevention of antibiotic-associated diarrhea प्रभाव: LGG OR 0.28 (0.17-0.47) for AAD prevention None

जनसंख्या: Patients on antibiotics

Key Statistics

3

अध्ययन

500

प्रतिभागी

Positive

C

ग्रेड

Referenced Papers

F1000Research 2016 63 उद्धरण
Journal of clinical … 2011 432 उद्धरण
International journal of … 2000 181 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
1-10 billion CFU/day
aadprevention:
6.5 billion CFU/day (Shirota strain)
immunesupport:
10 billion CFU/day

अधिकतम सीमा: Well-tolerated up to 20 billion CFU/day in clinical trials

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
4-strain probiotic mixture -- Positive --
None -- Positive 692
None 4.3 weeks Neutral 314
None -- Mixed 228
10 billion L. casei, 2 bottles/day 4.3 weeks Positive 32
None -- Positive 9569
None -- Mixed --
None -- Positive --

सेवन का सर्वोत्तम समय: With or without food; consistent daily timing recommended

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Mild gas and bloating during initial use
  • Occasional loose stools
  • Rare dairy-related reactions in lactose-sensitive individuals
  • Very rare: bacteremia in immunocompromised individuals

ज्ञात अंतःक्रियाएँ

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)

सहनीय अधिकतम सेवन: Well-tolerated up to 20 billion CFU/day in clinical trials

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Lactobacillus casei help with Antibiotic-Associated Diarrhea (AAD)?
Based on 3 studies with 500 participants, there is limited but promising evidence that Lactobacillus casei may support Antibiotic-Associated Diarrhea (AAD) management. Our evidence grade is C (Some Evidence).
How much Lactobacillus casei should I take for Antibiotic-Associated Diarrhea (AAD)?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus casei?
Reported side effects may include Mild gas and bloating during initial use, Occasional loose stools, Rare dairy-related reactions in lactose-sensitive individuals, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus casei and Antibiotic-Associated Diarrhea (AAD)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 500 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Antibiotic-Associated Diarrhea (AAD)

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।